Samuli Vaittinen

Institute of Biomedicine (Faculty of Medicine)

samuli.vaittinen@utu.fi

Kiinamyllynkatu 10

Turku

Added value of HPV-DNA in situ hybridization as an adjunct to p16 Immunohistochemistry in oropharyngeal squamous cell carcinoma (2025)
- Acta Oto-Laryngologica
Nissi, Linda; Huusko, Teemu; Routila, Johannes; Vaittinen, Samuli; Leivo, Ilmo; Irjala, Heikki; Ventela, Sami
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas (2023)
- Haematologica
Leivonen Suvi-Katri, Friman Terhi, Autio Matias, Vaittinen Samuli, Jensen Andreas Wind, d'Amore Francesco, Hamilton-Dutoit Stephen Jacques, Holte Harald, Beiske Klaus, Kovanen Panu E., Räty Riikka, Leppä Sirpa
Lymfoomien patologisanatominen diagnostiikka (2023)
- Duodecim
Kuittinen Outi, Aromaa-Häyhä Annikki, Böhm Jan, Hämäläinen Kirsi, Jyrkkiö Sirkku, Karjalainen-Lindsberg Marja-Liisa, Leppä Sirpa, Pollari Marjukka, Vaittinen Samuli, Vasala Kaija, Vornanen Martine, Kauppila Saila
Epidemiological Study of p16 Incidence in Head and Neck Squamous Cell Carcinoma 2005-2015 in a Representative Northern European Population (2022)
- Cancers
Mylly Mari, Nissi Linda, Huusko Teemu, Routila Johannes, Vaittinen Samuli, Irjala Heikki, Leivo Ilmo, Ventelä Sami
Structure-Activity Relationship of 3-Methylcytidine-5 '-alpha,beta-methylenediphosphates as CD73 Inhibitors (2022)
- Journal of Medicinal Chemistry
Scortichini Mirko, Idris Riham Mohammed, Moschutz Susanne, Keim Antje, Salmaso Veronica, Dobelmann Clemens, Oliva Paola, Losenkova Karolina, Irjala Heikki, Vaittinen Samuli, Sandholm Jouko, Yegutkin Gennady G, Sträter Norbert, Junker Anna, Müller Christa E, Jacobson Kenneth A
Structure activity relationship of 3-methylcytidine-5'-α,β-methylenediphosphates as CD73 inhibitors (2022)
- FASEB Journal
EB 2022 Jacobson Kenneth A., Scortichini Mirko, Idris Riham M., Moschütz Suzanne, Keim Antje, Salmaso Veronica A., Dobelmann Clemens, Oliva Paola A., Losenkova Karolina, Irjala Heikki, Vaittinen Samuli, Sandholm Jouko, Yegutkin Gennady G., Sträter Norbert, Junker Anna, Müller Christa E.
Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume (2021)
- Clinical and Translational Radiation Oncology
Nissi Linda, Suilamo Sami, Kytö Eero, Vaittinen Samuli, Irjala Heikki, Minn Heikki
Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes (2021)
- Frontiers in Oncology
Juntikka Tiina, Vaittinen Samuli, Vahlberg Tero, Jyrkkiö Sirkku, Minn Heikki
Epidemiological and treatment-related factors contribute to improved outcome of oropharyngeal squamous cell carcinoma in Finland (2018)
- Acta Oncologica
Lauri Jouhi, Elina Halme, Heikki Irjala, Kauko Saarilahti, Petri Koivunen, Matti Pukkila, Jaana Hagström, Caj Haglund, Paula Lindholm, Pasi Hirvikoski, Samuli Vaittinen, Anna Ellonen, Jukka Tikanto, Henry Blomster, Jussi Laranne, Reidar Grénman, Antti Mäkitie, Timo Atula
WHO:n lymfoomaluokitus uudistuu (2017)
- Moodi
Vaittinen S
Tumoral Expression of CD44 and HIF1α Predict Stage I Oral Cavity Squamous Cell Carcinoma Outcome (2016)
- Laryngoscope Investigative Otolaryngology
Dunkel J, Vaittinen S, Koivunen P, Laranne J, Mäkinen MJ, Tommola S, Irjala H
Prognostic markers in stage I oral cavity squamous cell carcinoma (2013)
- Laryngoscope
Dunkell Johannes, Vaittinen Samuli, Grénman Reidar, Kinnunen Ilpo, Irjala Heikki
Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients (2012)
- International Journal of Cancer
Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, Salmi M, Ristamaki R, Jalkanen S